[Therapy of shock using vaso- and coagulation-active substances. Behavior of tissue oxygen in the dog kidney under the influence of vaso- and coagulation-active substances].
D000804:Angiotensin II / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D004285:Dogs; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D012769:Shock / Q000188:drug therapy*; D013300:Streptokinase / Q000494:pharmacology / Q000627:therapeutic use*; D013917:Thrombin / Q000494:pharmacology / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000494:pharmacology / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D013300:Streptokinase; D013917:Thrombin; D009638:Norepinephrine
Zur Therapie des Schocks mit vaso- und gerinnungsaktiven Substanzen. Das Verhalten des Gewebssauerstoffes an der Hundeniere unter dem Einfluss vaso- und gerinnungsaktiver Substanzen.